Magali Remaud-Simeon
23Patents
6h-index
48Co-inventors
65Inventor score
Filing activity: Mar 18, 2002 → Jun 29, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7524645B2 | Fully active alternansucrases partially deleted in its carboxy-terminal and amino-terminal domains and mutants thereof | Chemistry; Metallurgy | 12 | Expired |
| US9512239B2 | Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans | Emerging Cross-Sectional Technologies | 10 | Active |
| US7439049B2 | Nucleic acid molecules coding for a dextran-saccharase catalysing the synthesis of dextran with α 1,2 osidic sidechains | Human Necessities | 7 | Expired |
| US8816067B2 | Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans | Emerging Cross-Sectional Technologies | 7 | Active |
| US7897373B2 | Construction of new variants of dextransucrase DSR-S by genetic engineering | Emerging Cross-Sectional Technologies | 6 | Active |
| US9399765B2 | Construction of new variants of dextransucrase DSR-S by genetic engineering | Emerging Cross-Sectional Technologies | 6 | Active |
| US7618951B2 | Use of prebiotics, preferably glucooligosaccharide, for the prevention of the onset of type II diabetes | Human Necessities | 3 | Expired |
| US8263380B2 | Construction of new variants of dextransucrase DSR-S by genetic engineering | Emerging Cross-Sectional Technologies | 3 | Active |
| US10167346B2 | Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans | Emerging Cross-Sectional Technologies | 1 | Active |
| US11253537B2 | Polypeptide having the ability to form connections of glucosyl units in alpha-1,3 on an acceptor | Chemistry; Metallurgy | 0 | Active |
| US9109207B2 | Construction of new variants of dextransucrase DSR-S by genetic engineering | Emerging Cross-Sectional Technologies | 0 | Active |
| US9688968B2 | Prebiotic composition or pharmaceutical composition synthesized from catalytic domains producing highly alpha-1,2 branched dextran | Human Necessities | 0 | Active |
| US9238829B2 | Method of production of 2,4-dihydroxybutyric acid | Chemistry; Metallurgy | 0 | Active |
| US10316300B2 | Protein with dextran-saccharase activity, and uses | Human Necessities | 0 | Active |
| US10842808B2 | Polypeptide having the capacity to form alpha-1,3 glucosyl unit branchings on an acceptor | Chemistry; Metallurgy | 0 | Active |
| US10358663B2 | Method of production of 2,4-dihydroxybutyric acid | Chemistry; Metallurgy | 0 | Active |
| US10017748B2 | Construction of new variants of dextransucrase DSR-S by genetic engineering | Emerging Cross-Sectional Technologies | 0 | Active |
| US9957488B2 | Pharmaceutical compositions and dermatogic compositions synthesized from catalytic domains producing highly α1,2 branched dextrans | Human Necessities | 0 | Active |
| US11834468B2 | Protected tetrasaccharides, their process of preparation and their use as transglucosylase acceptor substrates in the chemo-enzymatic synthesis of Shigella flexneri specific oligosaccharides | Chemistry; Metallurgy | 0 | Active |
| US10696995B2 | Enzymatic production of glycosylated synthons | Chemistry; Metallurgy | 0 | Active |
| US10308724B2 | Very high molar mass dextrans | Human Necessities | 0 | Active |
| US8758744B2 | Prebiotic composition or pharmaceutical composition synthesized from catalytic domains producing highly α-1,2 branched dextran | Human Necessities | 0 | Active |
| US10647739B2 | Flavonoids O-A-glucosylated on the B cycle, method for the production thereof and uses | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.